Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-24

Clinical Trial Update: 30000 IU Per Week Vitamin D Treatment in PCOS Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating 30,000 IU per week vitamin D in women with polycystic ovary syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Semmelweis University | Conditions: Polycystic Ovary Syndrome, Vitamin D Deficiency | Phase 2 | Status: COMPLETED